Cite
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase.
MLA
Albrecht, Brian K., et al. “Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the C-Met Kinase.” Journal of Medicinal Chemistry, vol. 51, no. 10, May 2008, pp. 2879–82. EBSCOhost, https://doi.org/10.1021/jm800043g.
APA
Albrecht, B. K., Harmange, J.-C., Bauer, D., Berry, L., Bode, C., Boezio, A. A., Chen, A., Choquette, D., Dussault, I., Fridrich, C., Hirai, S., Hoffman, D., Larrow, J. F., Kaplan-Lefko, P., Lin, J., Lohman, J., Long, A. M., Moriguchi, J., O’Connor, A., … Bellon, S. F. (2008). Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase. Journal of Medicinal Chemistry, 51(10), 2879–2882. https://doi.org/10.1021/jm800043g
Chicago
Albrecht, Brian K, Jean-Christophe Harmange, David Bauer, Loren Berry, Christiane Bode, Alessandro A Boezio, April Chen, et al. 2008. “Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the C-Met Kinase.” Journal of Medicinal Chemistry 51 (10): 2879–82. doi:10.1021/jm800043g.